Roche Alecensa gets European Commission nod as targeted adjuvant treatment for ALK-positive early-stage lung cancer Ruchika Sharma10 Jun 2024 10:00 AM ISTBasel: Roche announced today that the European Commission has approved Alecensa (alectinib) monotherapy, as adjuvant treatment following tumour...
Roche Alecensa gets USFDA nod for ALK-positive early-stage lung cancer Ruchika Sharma20 April 2024 12:05 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment following...
Roche Alecensa delivers unprecedented Phase III results for people with ALK positive early stage lung cancer Ruchika Sharma4 Sept 2023 1:30 PM ISTBasel: Roche has announced that the Phase III ALINA study evaluating Alecensa (alectinib), compared with platinum-based chemotherapy, met its primary...
Roche gets accelerated U.S. approval for lung cancer drug Meghna A Singhania13 Dec 2015 2:55 PM ISTU.S. health regulators on Friday said they have granted accelerated approval to Roche Holding's drug for advanced lung cancer in patients with a...
FDA approves Genentech drug for advanced lung cancer savita thakur thakur13 Dec 2015 2:39 PM ISTThe Food and Drug Administration has approved an experimental Genetech drug for patients with a certain type of lung cancer who have few other...
